Skip to content

Insider · CIK 0001864871

Flynn Patrick John

Reports to the SEC for 1 company · WILMINGTON, DE

Transactions

12

Companies

1

Filings

4

CIK

0001864871

Forms 4 and 5

Insider transactions

12 trades
DateCompanyValue
2025-04-09NRXPNRX Pharmaceuticals, Inc. · Stock Option (right to buy)A Award—
2022-11-28NRXPNRX Pharmaceuticals, Inc.P Purchase+$3,125
2022-11-28NRXPNRX Pharmaceuticals, Inc.P Purchase+$3,125
2022-11-28NRXPNRX Pharmaceuticals, Inc.P Purchase+$3,125
2022-11-28NRXPNRX Pharmaceuticals, Inc.P Purchase+$3,100
2022-11-28NRXPNRX Pharmaceuticals, Inc.P Purchase+$2,187.5
2022-10-21NRXPNRX Pharmaceuticals, Inc. · Employee Stock OptionA Award—
2021-05-24NRXPNRX Pharmaceuticals, Inc.A Award—
2021-05-24NRXPNRX Pharmaceuticals, Inc.A Award—
2021-05-24NRXPNRX Pharmaceuticals, Inc.A Award—
2021-05-24NRXPNRX Pharmaceuticals, Inc. · Common Stock Warrant (Right to buy)A Award—
2021-05-24NRXPNRX Pharmaceuticals, Inc. · Common Stock Warrant (Right to buy)A Award—

Recent filings

4

Companies

1

Address

C/O NRX PHARMACEUTICALS, INC. 1201 ORANGE STREET, SUITE 600

WILMINGTON, DE, 19801